Clarification1 Jun 2026, 04:07 pm
Astec Lifesciences Responds to Volume Increase Query
AI Summary
Astec Lifesciences Ltd. has responded to an exchange query regarding a significant increase in the volume of its security. The company confirms compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Astec states that there are no undisclosed developments requiring mandatory disclosure and assures adherence to all applicable regulations.
Key Highlights
- Astec Lifesciences addresses exchange query on security volume increase.
- Company confirms compliance with Listing Regulations.
- Company confirms compliance with Insider Trading Regulations.
- No mandatory disclosures are currently required.
- Astec assures continued compliance with regulations.
Price Impact
More from ASTEC